Show simple item record

dc.contributor.authorKoundouros, N
dc.contributor.authorPoulogiannis, G
dc.date.accessioned2020-05-28T11:09:27Z
dc.date.issued2020-01-07
dc.identifier.citationBritish journal of cancer, 2020, 122 (1), pp. 4 - 22
dc.identifier.issn0007-0920
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3647
dc.identifier.eissn1532-1827
dc.identifier.doi10.1038/s41416-019-0650-z
dc.description.abstractA common feature of cancer cells is their ability to rewire their metabolism to sustain the production of ATP and macromolecules needed for cell growth, division and survival. In particular, the importance of altered fatty acid metabolism in cancer has received renewed interest as, aside their principal role as structural components of the membrane matrix, they are important secondary messengers, and can also serve as fuel sources for energy production. In this review, we will examine the mechanisms through which cancer cells rewire their fatty acid metabolism with a focus on four main areas of research. (1) The role of de novo synthesis and exogenous uptake in the cellular pool of fatty acids. (2) The mechanisms through which molecular heterogeneity and oncogenic signal transduction pathways, such as PI3K-AKT-mTOR signalling, regulate fatty acid metabolism. (3) The role of fatty acids as essential mediators of cancer progression and metastasis, through remodelling of the tumour microenvironment. (4) Therapeutic strategies and considerations for successfully targeting fatty acid metabolism in cancer. Further research focusing on the complex interplay between oncogenic signalling and dysregulated fatty acid metabolism holds great promise to uncover novel metabolic vulnerabilities and improve the efficacy of targeted therapies.
dc.formatPrint-Electronic
dc.format.extent4 - 22
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectFatty Acids
dc.subjectSignal Transduction
dc.subjectLipogenesis
dc.subjectProto-Oncogene Proteins c-akt
dc.subjectPhosphatidylinositol 3-Kinases
dc.subjectTOR Serine-Threonine Kinases
dc.subjectTumor Microenvironment
dc.subjectCarcinogenesis
dc.subjectPhosphoinositide-3 Kinase Inhibitors
dc.subjectEpigenome
dc.titleReprogramming of fatty acid metabolism in cancer.
dc.typeJournal Article
dcterms.dateAccepted2019-11-01
rioxxterms.versionofrecord10.1038/s41416-019-0650-z
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBritish journal of cancer
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Signalling & Cancer Metabolism
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Signalling & Cancer Metabolism
pubs.publication-statusPublished
pubs.volume122
pubs.embargo.termsNot known
icr.researchteamSignalling & Cancer Metabolism
dc.contributor.icrauthorKoundouros, Nikolaos
dc.contributor.icrauthorPoulogiannis, Georgios


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0